Abstract
DNA methylation is associated with various diseases and aging; thus, longitudinal and repeated assessments of methylation patterns are crucial for revealing the mechanisms of disease onset and identifying factors associated with aging. The presence of batch effects influences the analysis of DNA methylation array data. Since existing methods for correcting batch effects are designed to correct all samples simultaneously, when data are incrementally measured and included, the correction of newly added data affects previous data. In this study, we propose an incremental framework for batch-effect correction based on ComBat, a location/scale adjustment approach using a Bayesian hierarchical model, and empirical Bayes estimation. Using numerical experiments and application to actual data, we demonstrate that the proposed method can correct newly included data without re-correcting the old data. The proposed method is expected to be useful for studies involving repeated measurements of DNA methylation, such as clinical trials of anti-aging interventions.
Full text
1,270 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
DNA methylation is associated with various diseases and aging; thus, longitudinal and repeated assessments of methylation patterns are crucial for revealing the mechanisms of disease onset and identifying factors associated with aging. The presence of batch effects influences the analysis of DNA methylation array data. Since existing methods for correcting batch effects are designed to correct all samples simultaneously, when data are incrementally measured and included, the correction of newly added data affects previous data. In this study, we propose an incremental framework for batch-effect correction based on ComBat, a location/scale adjustment approach using a Bayesian hierarchical model, and empirical Bayes estimation. Using numerical experiments and application to actual data, we demonstrate that the proposed method can correct newly included data without re-correcting the old data. The proposed method is expected to be useful for studies involving repeated measurements of DNA methylation, such as clinical trials of anti-aging interventions.
Competing Interest Statement
YT served as a technical advisor in statistical science for Rhelixa Inc., from April 2021 to March 2024. RN is the founder and chief executive officer of the company.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.